130 related articles for article (PubMed ID: 19654203)
1. Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Troch M; Zielinski C; Raderer M
Ann Oncol; 2009 Aug; 20(8):1446-7. PubMed ID: 19654203
[No Abstract] [Full Text] [Related]
2. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
Kuo SH; Cheng AL; Lin CW; Hsu CH; Wu MS; Yeh KH; Tzeng YS; Chen LT
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1387-95. PubMed ID: 21465313
[TBL] [Abstract][Full Text] [Related]
3. [Clarithromycin therapy of a B cell MALT lymphoma].
Danilko L; Haas K; Schönherr U; Tschurtschenthaler G
Ophthalmologe; 2013 May; 110(5):447-50. PubMed ID: 23224128
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).
Kiesewetter B; Troch M; Dolak W; Müllauer L; Lukas J; Zielinski CC; Raderer M
Haematologica; 2013 Mar; 98(3):353-6. PubMed ID: 22899582
[TBL] [Abstract][Full Text] [Related]
5. Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.
Kiesewetter B; Troch M; Mayerhoefer ME; Dolak W; Simonitsch-Klupp I; Raderer M
Oncologist; 2016 Jan; 21(1):72-5. PubMed ID: 26621040
[TBL] [Abstract][Full Text] [Related]
6. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
7. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
Celiker H; Toker E; Kaygusuz Atagunduz I
Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
[TBL] [Abstract][Full Text] [Related]
8. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency.
Desar IM; Keuter M; Raemaekers JM; Jansen JB; van Krieken JH; van der Meer JW
Neth J Med; 2006 May; 64(5):136-40. PubMed ID: 16702611
[TBL] [Abstract][Full Text] [Related]
9. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
10. Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy.
Yu CS; Chiu SI; Ng CS; Chan HH; Tse RK
Int Ophthalmol; 2008 Feb; 28(1):51-4. PubMed ID: 17589808
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival marginal zone B-cell lymphoma (MALT lymphoma) with amyloid and relapse in the stomach.
Topalkara A; Ben-Arie-Weintrob Y; Ferry JA; Foster CS
Ocul Immunol Inflamm; 2007; 15(4):347-50. PubMed ID: 17763134
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
Nückel H; Meller D; Steuhl KP; Dührsen U
Eur J Haematol; 2004 Oct; 73(4):258-62. PubMed ID: 15347312
[TBL] [Abstract][Full Text] [Related]
13. [Clarithromycin for monotherapy of B-cell MALT lymphoma?].
Auw-Hädrich C; Finke J; Serr A; Mittelviefhaus H; Bogdan C; Reinhard T
Ophthalmologe; 2013 Nov; 110(11):1076-8. PubMed ID: 24231914
[No Abstract] [Full Text] [Related]
14. Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Kiesewetter B; Simonitsch-Klupp I; Kornauth C; Dolak W; Lukas J; Mayerhoefer ME; Raderer M
Hematol Oncol; 2018 Feb; 36(1):62-67. PubMed ID: 28833354
[TBL] [Abstract][Full Text] [Related]
15. Intralesional interferon-α for the treatment of bilateral conjunctival mucosa-associated lymphoid tissue lymphoma.
Holds J; Buchanan A; Hanson R
Pediatr Blood Cancer; 2012 Jul; 59(1):176-8. PubMed ID: 21793177
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
Wu Y; Zhao L; Chai Y
Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
[TBL] [Abstract][Full Text] [Related]
17. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger G; Neumeister P; Brezinschek R; Hinterleitner T; Fiebiger W; Penz M; Neumann HJ; Mlineritsch B; DeSantis M; Quehenberger F; Chott A; Beham-Schmid C; Höfler G; Linkesch W; Raderer M
J Clin Oncol; 2002 Sep; 20(18):3872-7. PubMed ID: 12228207
[TBL] [Abstract][Full Text] [Related]
18. [Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma)].
Takahashi T; Suzumiya J
Nihon Rinsho; 2014 Mar; 72(3):493-8. PubMed ID: 24724410
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival malt lymphoma successfully treated with single agent rituximab therapy.
Salepci T; Seker M; Kurnaz E; Guler DO; Bilici A; Dane F; Aliustaoglu M; Atesoglu EB; Gumus M; Yaylaci M
Leuk Res; 2009 Mar; 33(3):e10-3. PubMed ID: 18653234
[No Abstract] [Full Text] [Related]
20. Helicobacter pylori (H. pylori) molecular signature in conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma.
Chan CC; Smith JA; Shen DF; Ursea R; LeHoang P; Grossniklaus HE
Histol Histopathol; 2004 Oct; 19(4):1219-26. PubMed ID: 15375765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]